Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Shaw

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Genetic control of insulin receptorsA E Goldfeld, C S Rubin, T W Siegel, et al.
Journal of Clinical Pharmacy and Therapeutics|December 17, 2016
Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature reviewT Jancel, P A Shaw, C W Hallahan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Trans regulation of the phosphoenolpyruvate carboxykinase (GTP) gene, identified by deletions in chromosome 7 of the mouseD S Loose, P A Shaw, K S Krauter, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cellsE Fibach, R Gambari, P A Shaw, et al.
Oncogene|July 13, 2006
Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progressionA Motamed-Khorasani, I Jurisica, M Letarte, et al.
BMJ Open|December 2, 2016
Randomised controlled trial of alternative messages to increase enrolment in a healthy food programme among individuals with diabetesA Gopalan, J Paramanund, P A Shaw, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 17, 2016
Mortality among patients with pulmonary non-tuberculous mycobacteria diseaseM Fleshner, K N Olivier, P A Shaw, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Differences between hereditary and sporadic ovarian cancerR P Zweemer, R H Verheijen, F H Menko, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2002
Histopathologic features of genetically determined ovarian cancerP A Shaw, J R McLaughlin, R P Zweemer, et al.
Journal of Clinical Pathology|November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutationsR P Zweemer, P A Shaw, R M Verheijen, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1981
Genetic control of insulin receptorsA E Goldfeld, C S Rubin, T W Siegel, et al.
Journal of Clinical Pharmacy and Therapeutics|December 17, 2016
Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature reviewT Jancel, P A Shaw, C W Hallahan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Trans regulation of the phosphoenolpyruvate carboxykinase (GTP) gene, identified by deletions in chromosome 7 of the mouseD S Loose, P A Shaw, K S Krauter, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cellsE Fibach, R Gambari, P A Shaw, et al.
Oncogene|July 13, 2006
Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progressionA Motamed-Khorasani, I Jurisica, M Letarte, et al.
BMJ Open|December 2, 2016
Randomised controlled trial of alternative messages to increase enrolment in a healthy food programme among individuals with diabetesA Gopalan, J Paramanund, P A Shaw, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 17, 2016
Mortality among patients with pulmonary non-tuberculous mycobacteria diseaseM Fleshner, K N Olivier, P A Shaw, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Differences between hereditary and sporadic ovarian cancerR P Zweemer, R H Verheijen, F H Menko, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2002
Histopathologic features of genetically determined ovarian cancerP A Shaw, J R McLaughlin, R P Zweemer, et al.
Journal of Clinical Pathology|November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutationsR P Zweemer, P A Shaw, R M Verheijen, et al.
Pageof 6